z-logo
Premium
Nocebo vs. Placebo: The Challenges of Trial Design in Analgesia Research
Author(s) -
Vase L,
Amanzio M,
Price DD
Publication year - 2015
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt.31
Subject(s) - placebo , nocebo , blinding , nocebo effect , expectancy theory , randomized controlled trial , clinical trial , medicine , clinical study design , physical therapy , intensive care medicine , psychology , alternative medicine , social psychology , pathology
The placebo effect in randomized clinical trials appears to have increased thereby contributing to problems of demonstrating statistically reliable effects of treatments that directly target biological mechanisms. The shortcomings of randomized clinical trials are currently discussed along with potential improvements of trial designs. In this review we explain how utilizing knowledge from the placebo and nocebo mechanisms literature could improve the information that can be obtained from randomized clinical trials. We present three major challenges in randomized clinical trials: (i) increasing placebo effects, (ii) variability of the placebo effect, and (iii) risk of un‐blinding. We then explain how recent placebo and nocebo studies of effects of verbal suggestion, expectancy, and emotions may improve understanding and discussion of increasing placebo effects, account/control for large parts of the variability of placebo effects, and suggest ways to improve blinding in future trials.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here